L., Shen H., Liu L., Wang L., Li B., Fang P., et al
Biosimilar Interchangeability Designation and Its Effect on Market Penetration Rate FDA biosimilar interchangeability designation, which allows pharmacists to substitute a biosimilar for a reference biologic without physician intervention, is an additional regulatory milestone beyond biosimilar approval itself
We were excited when we realize we had imaged this new planet, said the seasoned researcher Elisabeth Matthews from the Max Planck Institute for Astronomy in Heidelberg, Germany
Altogether, these data suggest that Fc-GLP-1 exhibits reduced efficacy in the context of NAFLD plus liver resection, an observation with a potential relevance in the clinical settings
Advantages of TB-500: Does not require blood draws or office procedures